CIK: 1463151 - Address: C/O Cardiff Oncology, Inc., 11055 Flintkote Ave, San Diego, CA 92121
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret11314131310-351
P%wins6767676767056

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/18/24 16:37
12/16/24
CRDFCardiff Oncology, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP.m374.76081368I
9/19/22 08:37
9/16/22
CRDFCardiff Oncology, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP471.5603010060D
9/13/21 08:12
9/10/21
CRDFCardiff Oncology, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP1946.47030New30D
11/12/20 06:00
11/10/20
CDTXCidara Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP1012.0105076116I
3/23/20 19:12
9/24/19
CDTXCidara Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP.a571.91030New30D
9/26/19 21:17
9/24/19
CDTXCidara Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLevine James E.CAOCFOP571.9103017205D
5/16/12 17:29
5/15/12
VRNMVerenium CorpDEChemOChmIndustrial Organic ChemicalsLevine James E.CADOCEOP183.65055109D
8/29/11 15:25
8/25/11
VRNMVerenium CorpDEChemOChmIndustrial Organic ChemicalsLevine James E.CADOCEOP803.1802532104D-61-3-5508510958312-13-15-13-10
8/16/11 15:19
8/12/11
VRNMVerenium CorpDEChemOChmIndustrial Organic ChemicalsLevine James E.CADOEVP,CEOP421.690254679D-74-22-36-1219222133-35512531
8/17/10 17:17
8/13/10
VRNMVerenium CorpDEChemOChmIndustrial Organic ChemicalsLevine James E.MAOEVP,CFOP.m1252.51050999%54D-92-66-52-2191124194269-35

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact